Cargando…
Phage Display-Based Homing Peptide-Daunomycin Conjugates for Selective Drug Targeting to PANC-1 Pancreatic Cancer
The Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most aggressive and dangerous cancerous diseases, leading to a high rate of mortality. Therefore, the development of new, more efficient treatment approaches is necessary to cure this illness. Peptide-based drug targeting provides a new tool...
Autores principales: | Dókus, Levente E., Lajkó, Eszter, Ranđelović, Ivan, Mező, Diána, Schlosser, Gitta, Kőhidai, László, Tóvári, József, Mező, Gábor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355684/ https://www.ncbi.nlm.nih.gov/pubmed/32580307 http://dx.doi.org/10.3390/pharmaceutics12060576 |
Ejemplares similares
-
Overcharging Effect in Electrospray Ionization Mass Spectra of Daunomycin-Tuftsin Bioconjugates
por: Pethő, Lilla, et al.
Publicado: (2019) -
Apoptotic Effects of Drug Targeting Conjugates Containing Different GnRH Analogs on Colon Carcinoma Cells
por: Lajkó, Eszter, et al.
Publicado: (2019) -
Development of novel cyclic NGR peptide–daunomycin conjugates with dual targeting property
por: Tripodi, Andrea Angelo Pierluigi, et al.
Publicado: (2018) -
Structural Characterization of Daunomycin-Peptide Conjugates by Various Tandem Mass Spectrometric Techniques
por: Borbély, Adina, et al.
Publicado: (2021) -
Influence of the Drug Position on Bioactivity in Angiopep-2—Daunomycin Conjugates
por: Pethő, Lilla, et al.
Publicado: (2023)